Cefpimizole sodium
| Code | Size | Price |
|---|
| TAR-T25223-5mg | 5mg | £850.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Documents
Further Information
Bioactivity:
Cefpimizole sodium is a Semisynthetic cephalosporin with antibacterial activity.
CAS:
85287-61-2
Formula:
C28H25N6NaO10S2
Molecular Weight:
692.65
Purity:
0.98
SMILES:
[Na+].OC(=O)C1=C(C[n+]2ccc(CCS([O-])(=O)=O)cc2)CSC2C(NC(=O)C(NC(=O)c3nc[nH]c3C([O-])=O)c3ccccc3)C(=O)N12
References
1. Periti P. Immunopharmacology of oral betalactams. J Chemother. 1998 Apr;10(2):91-6. Review. PubMed PMID: 9603632.
2. Toyoguchi T, Nakagawa Y. [Nephrotoxicity and drug interaction of vancomycin (2)]. Nihon Yakurigaku Zasshi. 1996 May;107(5):225-35. Japanese. PubMed PMID: 8690304.
3. Araki A, Sendo F. Reduced anti-Pseudomonas aeruginosa activity of a cephalosporin, cefodizime, in rats whose neutrophils were selectively depleted by a monoclonal antibody. Microbiol Immunol. 1996;40(5):333-8. PubMed PMID: 8999285.
4. Ueta E, Yoneda K, Yamamoto T, Osaki T. Upregulatory effects of cefpimizole natrium on human leukocytes. Int J Immunopharmacol. 1992 Jul;14(5):877-85. PubMed PMID: 1324894.